These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 23980519)
1. PTEN hypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma. Pan QF; Li WT; Dong HC; Chen YZ; Yin L; Liu W; Wang WW; Liu D; Li SG; Gu WY; Chen JZ; Yang L; Zhang WJ; Li F Dis Esophagus; 2014; 27(4):396-402. PubMed ID: 23980519 [TBL] [Abstract][Full Text] [Related]
2. PTEN gene is infrequently hypermethylated in human esophageal squamous cell carcinoma. Sun Z; Ji N; Bi M; Wang S; Liu X; Wang Z Tumour Biol; 2015 Aug; 36(8):5849-57. PubMed ID: 25724185 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma. Cui X; Zhao Z; Liu D; Guo T; Li S; Hu J; Liu C; Yang L; Cao Y; Jiang J; Liang W; Liu W; Li S; Wang L; Wang L; Gu W; Wu C; Chen Y; Li F J Exp Clin Cancer Res; 2014 Feb; 33(1):20. PubMed ID: 24528540 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of miR-203 in Kazakh patients with esophageal squamous cell carcinoma by MassARRAY spectrometry. Cui X; Chen X; Wang W; Chang A; Yang L; Liu C; Peng H; Wei Y; Liang W; Li S; Wang N; Liu W; Hu J; Zhang W; Wang L; Chen Y; Li F Epigenetics; 2017 Aug; 12(8):698-707. PubMed ID: 28703658 [TBL] [Abstract][Full Text] [Related]
5. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients. Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma. Sheyhidin I; Hasim A; Zheng F; Ma H Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465 [TBL] [Abstract][Full Text] [Related]
7. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development. Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858 [TBL] [Abstract][Full Text] [Related]
8. LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak's esophageal squamous cell carcinomas. Zheng F; Hasim A; Anwer J; Niyaz M; Sheyhidin I Mol Biol Rep; 2013 Mar; 40(3):2069-75. PubMed ID: 23283737 [TBL] [Abstract][Full Text] [Related]
9. HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC. Hu JM; Li L; Chen YZ; Liu C; Cui X; Yin L; Yang L; Zou H; Pang L; Zhao J; Qi Y; Cao Y; Jiang J; Liang W; Li F Epigenetics; 2014 Oct; 9(10):1366-73. PubMed ID: 25437052 [TBL] [Abstract][Full Text] [Related]
10. Negative expression of PTEN identifies high risk for lymphatic-related metastasis in human esophageal squamous cell carcinoma. Sun Z; Ji N; Bi M; Zhang Z; Liu X; Wang Z Oncol Rep; 2015 Jun; 33(6):3024-32. PubMed ID: 25963289 [TBL] [Abstract][Full Text] [Related]
12. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma. Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960 [TBL] [Abstract][Full Text] [Related]
13. Aberrant promoter 2 methylation‑mediated downregulation of protein tyrosine phosphatase, non‑receptor type 6, is associated with progression of esophageal squamous cell carcinoma. Liu L; Zhang S; Liu X; Liu J Mol Med Rep; 2019 Apr; 19(4):3273-3282. PubMed ID: 30816454 [TBL] [Abstract][Full Text] [Related]
14. Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124 [TBL] [Abstract][Full Text] [Related]
15. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer. Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812 [TBL] [Abstract][Full Text] [Related]
17. Association of roasting meat intake with the risk of esophageal squamous cell carcinoma of Kazakh Chinese via affecting promoter methylation of p16 gene. Chen W; Yang C; Yang L; Qi C; Tian S; Han Y; Dou Y; Ma Y; Tian D; Zheng Y Asia Pac J Clin Nutr; 2014; 23(3):488-97. PubMed ID: 25164462 [TBL] [Abstract][Full Text] [Related]
18. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma. Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475 [TBL] [Abstract][Full Text] [Related]
19. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma. Ma K; Cao B; Guo M Clin Epigenetics; 2016; 8():43. PubMed ID: 27110300 [TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma. Li JS; Ying JM; Wang XW; Wang ZH; Tao Q; Li LL Chin J Cancer; 2013 Jan; 32(1):3-11. PubMed ID: 22572016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]